Risk characteristics of obesity and atherosclerotic cardiovascular events in patients with schizophrenia: A single-center 10-year retrospective cohort study

Table 8 Subgroup analysis of obesity-associated cardiovascular risk in our hospital population

Subgroup	n	MACE events, n (%)	Obesity hazard ratios (95% confidence interval)	P interaction
Age group				0.012
18-35 years	2834	234 (8.3)	3.12 (2.56-3.80)
36-50 years	4123	756 (18.3)	2.45 (2.12-2.83)
51-65 years	3043	852 (28.0)	1.98 (1.71-2.29)
Sex				0.003
Male	5820	1123 (19.3)	2.12 (1.86-2.41)
Female	4180	719 (17.2)	2.78 (2.34-3.30)
Illness duration at our facility				0.045
< 5 years	3421	423 (12.4)	2.89 (2.43-3.44)
5-15 years	3876	734 (18.9)	2.34 (2.01-2.72)
> 15 years	2703	685 (25.3)	1.98 (1.68-2.33)
Antipsychotic risk				0.021
High risk	3890	823 (21.2)	2.67 (2.29-3.11)
Moderate risk	2987	543 (18.2)	2.23 (1.87-2.66)
Low risk	1857	287 (15.5)	1.89 (1.49-2.40)

MACE: Major adverse cardiovascular events.